Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $605189.0.

  • Silo Pharma's Other Operating Expenses rose 1888.06% to $605189.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 73.06%. This contributed to the annual value of $2.4 million for FY2024, which is 1052.93% down from last year.
  • As of Q3 2025, Silo Pharma's Other Operating Expenses stood at $605189.0, which was up 1888.06% from $547870.0 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Other Operating Expenses registered a high of $934665.0 during Q4 2022, and its lowest value of $308863.0 during Q2 2021.
  • Its 5-year average for Other Operating Expenses is $575218.2, with a median of $547870.0 in 2025.
  • Over the last 5 years, Silo Pharma's Other Operating Expenses had its largest YoY gain of 64231.29% in 2021, and its largest YoY loss of 6801.39% in 2021.
  • Over the past 5 years, Silo Pharma's Other Operating Expenses (Quarter) stood at $461434.0 in 2021, then surged by 102.56% to $934665.0 in 2022, then decreased by 9.77% to $843325.0 in 2023, then decreased by 10.57% to $754199.0 in 2024, then decreased by 19.76% to $605189.0 in 2025.
  • Its last three reported values are $605189.0 in Q3 2025, $547870.0 for Q2 2025, and $516725.0 during Q1 2025.